Angiotensin Receptor Blockers Are Associated with Reduced Fibrosis and Interleukin-6 Expression in Calcific Aortic Valve Disease

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Pathobiology (Basel)

• Publication date

  2013-08-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000350896PMID 23969418
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interleukin 6 Underlies Angiotensin II–Induced Hypertension and Chronic Renal Damage

  2012cited by this paper
• Macrophage-Stimulated Cardiac Fibroblast Production of IL-6 Is Essential for TGF β/Smad Activation and Cardiac Fibrosis Induced by Angiotensin II

  2012cited by this paper
• Calcific aortic valve disease: not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update.

  2011cited by this paper
• Angiotensin receptor blockers are associated with a lower remodelling score of stenotic aortic valves

  2011cited by this paper
• Obesity, Inflammation, and Cardiovascular Risk

  2010cited by this paper
• Oxidized low-density lipoprotein, angiotensin II and increased waist cirumference are associated with valve inflammation in prehypertensive patients with aortic stenosis.

  2010cited by this paper
• Visceral Obesity: The Link Among Inflammation, Hypertension, and Cardiovascular Disease

  2009cited by this paper
• Refining Molecular Pathways Leading to Calcific Aortic Valve Stenosis by Studying Gene Expression Profile of Normal and Calcified Stenotic Human Aortic Valves

  2009cited by this paper
• Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.

  2008cited by this paper
• Visceral obesity and the heart.

  2008cited by this paper
• Re: P Mathieu, JP Després, P Pibarot. The 'valvulo-metabolic' risk in calcific aortic valve disease. Can J Cardiol 2007;23(Suppl B): 32B-39B.

  2008cited by this paper
• Angiotensin receptor-1 blocker inhibits atherosclerotic changes and endothelial disruption of the aortic valve in hypercholesterolemic rabbits.

  2007cited by this paper
• Association Between Plasma LDL Particle Size, Valvular Accumulation of Oxidized LDL, and Inflammation in Patients With Aortic Stenosis

  2007cited by this paper
• The 'valvulo-metabolic' risk in calcific aortic valve disease.

  2007cited by this paper
• Association between circulating oxidised low-density lipoprotein and fibrocalcific remodelling of the aortic valve in aortic stenosis

  2007cited by this paper
• Metabolic syndrome negatively influences disease progression and prognosis in aortic stenosis.

  2006cited by this paper
• Features of the Metabolic Syndrome and Diabetes Mellitus as Predictors of Aortic Valve Calcification in the Multi-Ethnic Study of Atherosclerosis

  2006cited by this paper
• Angiotensin-converting enzyme inhibitors and change in aortic valve calcium.

  2005cited by this paper
• Letter regarding article by Rosenhek et al, "statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis".

  2005cited by this paper
• Statins but Not Angiotensin-Converting Enzyme Inhibitors Delay Progression of Aortic Stenosis

  2004cited by this paper
• Induction of local angiotensin II-producing systems in stenotic aortic valves.

  2004cited by this paper
• Association of Angiotensin-Converting Enzyme With Low-Density Lipoprotein in Aortic Valvular Lesions and in Human Plasma

  2002cited by this paper
• Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study.

  1997cited by this paper

• Precision RNA interference of Smad3 and Runx2 via dual targeting nanocarriers mitigates aortic valve disease

  2026cites this paper
• Valvular calcification in chronic kidney disease: new insights from recent clinical and preclinical studies

  2025cites this paper
• Detrimental Effect of Plasma From Patients With Severe Aortic Stenosis on Valvular Endothelial Cells: Role of Proinflammatory Cytokines and Factor Xa.

  2025cites this paper
• Monocytes at the crossroads of aortic stenosis and myocardial damage.

  2025cites this paper
• Macrophages as key modulators of calcific aortic valve disease

  2025cites this paper
• Valvular Interstitial Cells as a novel therapeutic target for preventing Calcific Aortic Valve Disease.

  2025cites this paper
• Decreased Prevalence of New-Onset Adhesive Capsulitis in Patients Prescribed Angiotensin Receptor Blockers.

  2024cites this paper
• Integrated machine learning and Mendelian randomization reveal PALMD as a prognostic biomarker for nonspecific orbital inflammation

  2024cites this paper
• Angiotensin II receptor blockers are associated with reduced valvular fibrosis in females with aortic stenosis.

  2024cites this paper
• Spontaneous Epiretinal Membrane Resolution and Angiotensin Receptor Blockers: Case Observation, Literature Review and Perspectives

  2023cites this paper
• The effect of immunomodulatory drugs on aortic stenosis: a Mendelian randomisation analysis

  2023cites this paper
• Integrative Analysis of the Blood Proteome by Mendelian Randomization Reveals Regulatory Networks in Calcific Aortic Valve Disease

  2023cites this paper
• Calcific aortic valve disease: mechanisms, prevention and treatment

  2023cites this paper
• IL6 gene polymorphism association with calcific aortic valve stenosis and influence on serum levels of interleukin-6

  2022cites this paper
• Cellular Senescence, Aging and Non-Aging Processes in Calcified Aortic Valve Stenosis: From Bench-Side to Bedside

  2022cites this paper
• Sestrin2 Is Increased in Calcific Aortic Disease and Inhibits Osteoblastic Differentiation in Valvular Interstitial Cells via the Nuclear Factor E2–related Factor 2 Pathway

  2022cites this paper
• Contrast-enhanced computed tomography assessment of aortic stenosis

  2021cites this paper
• Towards Personalized Therapy of Aortic Stenosis

  2021cites this paper
• Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapy.

  2021cites this paper
• Interferons Are Pro-Inflammatory Cytokines in Sheared-Stressed Human Aortic Valve Endothelial Cells

  2021cites this paper
• NOTCH Signaling in Aortic Valve Development and Calcific Aortic Valve Disease

  2021cites this paper
• Changing epidemiology of calcific aortic valve disease: 30-year trends of incidence, prevalence, and deaths across 204 countries and territories

  2021cites this paper
• Correlation Between Cardiac Computed Tomography and Histopathology for Evaluating Patients with Aortic Valve Disease.

  2021cites this paper
• Age, Sex, and Valve Phenotype Differences in Fibro‐Calcific Remodeling of Calcified Aortic Valve

  2020cites this paper
• Association of aortic valve calcification and vitamin K antagonist treatment.

  2020cites this paper
• Current Evidence and Future Perspectives on Pharmacological Treatment of Calcific Aortic Valve Stenosis

  2020cites this paper
• Effects of angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker on one-year outcomes of patients with atrial fibrillation: insights from a multicenter registry study in China

  2020cites this paper
• Chronic Kidney Disease and the Pathophysiology of Valvular Heart Disease.

  2019cites this paper
• Molecular Mechanisms of Aortic Valve Pathology

  2019cites this paper
• Targeting the autotaxin - Lysophosphatidic acid receptor axis in cardiovascular diseases.

  2019cites this paper
• Aortic stenosis and diabetes mellitus: An ominous combination

  2019cites this paper
• Liraglutide attenuates cardiac remodeling and improves heart function after abdominal aortic constriction through blocking angiotensin II type 1 receptor in rats

  2019cites this paper
• Degenerative Aortic Stenosis, Dyslipidemia and Possibilities of Medical Treatment

  2018cites this paper
• Sex-Related Discordance Between Aortic Valve Calcification and Hemodynamic Severity of Aortic Stenosis: Is Valvular Fibrosis the Explanation?

  2017cites this paper
• Elevated Serotonin Interacts with Angiotensin-II to Result in Altered Valve Interstitial Cell Contractility and Remodeling

  2017cites this paper
• Human interstitial cellular model in therapeutics of heart valve calcification

  2017cites this paper
• Calcific aortic valve stenosis: hard disease in the heart

  2017cites this paper
• The angiotensin II type 1 receptor blocker losartan attenuates bioprosthetic valve leaflet calcification in a rabbit intravascular implant model.

  2016cites this paper
• Fibrotic Aortic Valve Stenosis in Hypercholesterolemic/Hypertensive Mice

  2016cites this paper
• Impact du phénotype de la valve aortique et de l'âge sur la relation entre la calcification valvulaire aortique et la sévérité hémodynamique de la sténose aortique : étude PROGRESSA

  2016cites this paper
• Pathological Investigation of Congenital Bicuspid Aortic Valve Stenosis, Compared with Atherosclerotic Tricuspid Aortic Valve Stenosis and Congenital Bicuspid Aortic Valve Regurgitation

  2016cites this paper
• Effect of age and aortic valve anatomy on calcification and haemodynamic severity of aortic stenosis

  2016cites this paper
• Cardiac Fibrosis and Heart Failure: Cause or Effect?

  2015cites this paper
• Genomics to elucidate the molecular basis of calcific aortic valve disease

  2015cites this paper
• The effects of angiotensin receptor blockers on outcomes of Chinese patients with atrial fibrillation.

  2015cites this paper
• Innate and Adaptive Immunity in Calcific Aortic Valve Disease

  2015cites this paper
• Current and Future Strategies for the Diagnosis and Treatment of Cardiac Fibrosis

  2015cites this paper
• Identificación de modificaciones epigenéticas como posibles biomarcadores de la obesidad y el ictus

  2014cites this paper
• Basic mechanisms of calcific aortic valve disease.

  2014cites this paper
• Circulating levels of matrix gla protein and progression of aortic stenosis: a substudy of the Aortic Stenosis Progression Observation: Measuring Effects of rosuvastatin (ASTRONOMER) trial.

  2014cites this paper
• P2Y2 receptor represses IL-6 expression by valve interstitial cells through Akt: implication for calcific aortic valve disease.

  2014cites this paper
• Molecular biology of calcific aortic valve disease: towards new pharmacological therapies

  2014cites this paper
• Research update for articles published in EJCI in 2011

  2013cites this paper
• Research update for articles published in EJCI in 2012

  2013cites this paper